Form 3794-2026

Get Form
instructions form fda Preview on Page 1

Here's how it works

01. Edit your instructions form fda online
Type text, add images, blackout confidential details, add comments, highlights and more.
02. Sign it in a few clicks
Draw your signature, type it, upload its image, or use your mobile device as a signature pad.
03. Share your form with others
Send instructions fda via email, link, or fax. You can also download it, export it or print it out.

How to use or fill out form 3794 with our platform

Form edit decoration
9.5
Ease of Setup
DocHub User Ratings on G2
9.0
Ease of Use
DocHub User Ratings on G2
  1. Click ‘Get Form’ to open Form FDA 3794 in the editor.
  2. Begin by filling out the 'APPLICANT, HOLDER OR OWNER' section with the legal name and address of the entity submitting the application.
  3. In the 'REPRESENTATIVE OR U.S. AGENT' field, provide contact details for a person authorized to respond to FDA inquiries, ensuring they are a U.S. agent if applicable.
  4. Indicate the relevant 'FISCAL YEAR' for your submission, noting that it starts on October 1 of the previous calendar year.
  5. Select the appropriate 'GENERIC DRUG USER FEE TYPE' by checking the corresponding box for ANDA, PAS, Type II API DMF, or backlog fee.
  6. Complete sections related to ANDA/PAS information by entering application numbers and product names as required.
  7. Fill in facility information including name, address, FEI number, and DUNS number as necessary.
  8. Review all entries for accuracy before submitting your completed form through our platform.

Start using our platform today to streamline your form completion process for free!

See more form 3794 versions

We've got more versions of the form 3794 form. Select the right form 3794 version from the list and start editing it straight away!
Versions Form popularity Fillable & printable
2013 4.8 Satisfied (118 Votes)
2012 4.4 Satisfied (346 Votes)
be ready to get more

Complete this form in 5 minutes or less

Get form

Got questions?

We have answers to the most popular questions from our customers. If you can't find an answer to your question, please contact us.
Contact us
If the FDA finds any non-compliance issues during the audit, the manufacturer may receive a Form 483 or Warning Letter, which may require corrective action to be taken before the FDA will allow the manufacturer to continue to market their medical devices.
Under the GDUFA II framework, correspondence seeking regulatory and/or scientific advice after issuance of a Complete Response Letter or tentative approval, or after ANDA approval, was considered general correspondence. Under GDUFA III, these types of correspondence can be submitted as controlled correspondence.
Also known as a notice of inspection, the Food and Drug Administration (FDA) Form 482 is an official document presented to the investigator upon arrival at the study site that gives the FDA the authority to access, inspect and copy any required records related to the clinical investigation.
The Form FDA 483 notifies the companys management of observed objectionable conditions. At the conclusion of an inspection, the Form FDA 483 is presented and discussed with the companys senior management. Is the Form FDA 483 intended to be an all-inclusive list ?
While a company is not legally required to respond to an FDA 483, it is highly recommended. A prompt and thorough response can demonstrate the companys commitment to compliance and address the issues raised. The response should outline corrective actions taken or planned to address the observations.

Security and compliance

At DocHub, your data security is our priority. We follow HIPAA, SOC2, GDPR, and other standards, so you can work on your documents with confidence.

Learn more
ccpa2
pci-dss
gdpr-compliance
hipaa
soc-compliance
be ready to get more

Complete this form in 5 minutes or less

Get form